NASDAQ · LGND
Ligand Pharmaceuticals Incorporated
$320.13+$2.80 (+0.88%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
Loading market information…
OTC · ARPC · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Arem Pacific Corporation’s quoted price sits in the lower half of its reported 52-week range, 70.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Arem Pacific Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Melbourne, Australia, Arem Pacific Corporation specializes in providing a diverse range of therapeutic and wellness services. Their extensive offerings include acupressure and reflexology treatments, various massage options such as neck, shoulder, back, leg, full body, foot, deep tissue, and hot oil, along with cupping therapy.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$320.13+$2.80 (+0.88%)
Ligand Pharmaceuticals Incorporated’s quoted price sits in the upper half of its reported 52-week range, 2.04% below the high.
$0.50$0.00 (0.0%)
CYduct Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.76% below the high.
$0.18$0.00 (0.0%)
Procyon Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.71% below the high.
$0.00$0.00 (0.0%)
PharmaCom BioVet, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
€0.88+€0.01 (+0.57%)
Epigenomics AG’s quoted price sits in the lower half of its reported 52-week range, 44.97% below the high.
$0.07$0.00 (0.0%)
Mid-Atlantic Home Health Network, Inc.’s quoted price sits in the lower half of its reported 52-week range, 92.13% below the high.
$0.02-$0.00 (-8.26%)
China Medicine Corp.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
$0.02$0.00 (0.0%)
Health Logic Interactive Inc.’s quoted price sits in the upper half of its reported 52-week range, 45.21% below the high.
